Filter
908
Text search:
clinical
algorithm
Featured
155
242
Language
Document type
427
230
122
69
22
21
9
5
2
Countries
71
38
31
29
29
28
18
17
17
15
13
13
13
12
10
9
8
8
8
8
7
7
6
6
6
6
6
6
6
5
4
4
4
4
4
4
4
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
358
144
54
39
25
15
14
Toolboxes
137
77
63
61
56
34
33
21
19
17
15
13
11
10
8
6
6
5
5
5
4
3
2
2
National Tuberculosis and Leprosy Control Program
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Policy framework.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
What We Know, What We Don’t Know, and What We Need to Do
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte ...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte ...
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Training for staff working at DR-TB management centres.
Training modules
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
